Haemonetics Corporation Cost of Revenue
Haemonetics Corporation (HAE) reported Cost of Revenue of $136.58 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- Haemonetics Corporation cost of goods and services sold for the quarter ending 2026-06-27 was $136.58M, a 5.75% increase year-over-year.
- Haemonetics Corporation cost of goods and services sold for the quarter ending 2026-03-28 was $148.14M, a 7.70% increase year-over-year.
- Haemonetics Corporation cost of goods and services sold for the quarter ending 2025-12-27 was $136.58M, a 11.88% decline year-over-year.
- Haemonetics Corporation cost of goods and services sold for the quarter ending 2025-09-27 was $132.57M, a 16.13% decline year-over-year.
- Haemonetics Corporation cost of goods and services sold for fiscal 2026 was $546.44M, a 10.69% decline from fiscal 2025.
- Haemonetics Corporation cost of goods and services sold for fiscal 2025 was $611.87M, a 0.91% decline from fiscal 2024.
- Haemonetics Corporation cost of goods and services sold for fiscal 2024 was $617.51M, a 11.55% increase from fiscal 2023.
- Haemonetics Corporation cost of goods and services sold for fiscal 2023 was $553.56M, a 13.51% increase from fiscal 2022.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-27 | $136.58M 10-Q · filed 2026-08-06 | $284.72M derived: sum of 2 quarters · filed 2026-08-06 | $421.30M derived: sum of 3 quarters · filed 2026-08-06 | $553.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-28 | $148.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $284.72M derived: sum of 2 quarters · filed 2026-05-20 | $417.29M derived: sum of 3 quarters · filed 2026-05-20 | $546.44M 10-K · filed 2026-05-20 |
| 2025-12-27 | $136.58M 10-Q · filed 2026-02-05 | $269.15M derived: sum of 2 quarters · filed 2026-02-05 | $398.30M 10-Q · filed 2026-02-05 | $535.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-27 | $132.57M 10-Q · filed 2025-11-06 | $261.72M 10-Q · filed 2025-11-06 | $399.27M derived: sum of 3 quarters · filed 2026-08-06 | $554.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-28 | $129.15M 10-Q · filed 2026-08-06 | $266.70M derived: sum of 2 quarters · filed 2026-08-06 | $421.69M derived: sum of 3 quarters · filed 2026-08-06 | $579.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-29 | $137.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $292.54M derived: sum of 2 quarters · filed 2026-05-20 | $450.62M derived: sum of 3 quarters · filed 2026-05-20 | $611.87M 10-K · filed 2026-05-20 |
| 2024-12-28 | $155.00M 10-Q · filed 2026-02-05 | $313.07M derived: sum of 2 quarters · filed 2026-02-05 | $474.32M 10-Q · filed 2026-02-05 | $641.70M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-09-28 | $158.07M 10-Q · filed 2025-11-06 | $319.32M 10-Q · filed 2025-11-06 | $486.71M derived: sum of 3 quarters · filed 2026-05-20 | $645.09M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-06-29 | $161.25M 10-Q · filed 2025-08-07 | $328.63M derived: sum of 2 quarters · filed 2026-05-20 | $487.01M derived: sum of 3 quarters · filed 2026-05-20 | $634.69M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-03-30 | $167.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $325.77M derived: sum of 2 quarters · filed 2026-05-20 | $473.44M derived: sum of 3 quarters · filed 2026-05-20 | $617.51M 10-K · filed 2026-05-20 |
| 2023-12-30 | $158.38M 10-Q · filed 2025-02-06 | $306.06M derived: sum of 2 quarters · filed 2025-02-06 | $450.12M 10-Q · filed 2025-02-06 | $598.29M derived: sum of 4 quarters · filed 2025-05-21 |
| 2023-09-30 | $147.67M 10-Q · filed 2024-11-07 | $291.74M 10-Q · filed 2024-11-07 | $439.91M derived: sum of 3 quarters · filed 2025-05-21 | $586.50M derived: sum of 4 quarters · filed 2025-05-21 |
| 2023-07-01 | $144.07M 10-Q · filed 2024-08-08 | $292.23M derived: sum of 2 quarters · filed 2025-05-21 | $438.83M derived: sum of 3 quarters · filed 2025-05-21 | $578.43M derived: sum of 4 quarters · filed 2025-05-21 |
| 2023-04-01 | $148.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-21 | $294.76M derived: sum of 2 quarters · filed 2025-05-21 | $434.37M derived: sum of 3 quarters · filed 2025-05-21 | $553.56M 10-K · filed 2025-05-21 |
| 2022-12-31 | $146.59M 10-Q · filed 2024-02-08 | $286.20M derived: sum of 2 quarters · filed 2024-02-08 | $405.40M 10-Q · filed 2024-02-08 | $534.09M derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-10-01 | $139.61M 10-Q · filed 2023-11-02 | $258.80M 10-Q · filed 2023-11-02 | $387.49M derived: sum of 3 quarters · filed 2024-05-20 | $508.70M derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-07-02 | $119.19M 10-Q · filed 2023-08-08 | $247.89M derived: sum of 2 quarters · filed 2024-05-20 | $369.09M derived: sum of 3 quarters · filed 2024-05-20 | $486.45M derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-04-02 | $128.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-20 | $249.90M derived: sum of 2 quarters · filed 2024-05-20 | $367.25M derived: sum of 3 quarters · filed 2024-05-20 | $487.69M 10-K · filed 2024-05-20 |
| 2022-01-01 | $121.20M 10-Q · filed 2023-02-07 | $238.56M derived: sum of 2 quarters · filed 2023-02-07 | $359.00M 10-Q · filed 2023-02-07 | $502.23M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-10-02 | $117.36M 10-Q · filed 2022-11-08 | $237.80M 10-Q · filed 2022-11-08 | $381.02M derived: sum of 3 quarters · filed 2023-05-22 | $501.13M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-07-03 | $120.44M 10-Q · filed 2022-08-10 | $263.67M derived: sum of 2 quarters · filed 2023-05-22 | $383.78M derived: sum of 3 quarters · filed 2023-05-22 | $487.52M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-04-03 | $143.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-22 | $263.34M derived: sum of 2 quarters · filed 2023-05-22 | $367.08M derived: sum of 3 quarters · filed 2023-05-22 | $472.63M 10-K · filed 2023-05-22 |
| 2020-12-26 | $120.11M 10-Q · filed 2022-02-08 | $223.86M derived: sum of 2 quarters · filed 2022-02-08 | $329.40M 10-Q · filed 2022-02-08 | $454.34M derived: sum of 4 quarters · filed 2022-05-25 |
| 2020-09-26 | $103.74M 10-Q · filed 2021-11-09 | $209.29M 10-Q · filed 2021-11-09 | $334.22M derived: sum of 3 quarters · filed 2022-05-25 | $465.14M derived: sum of 4 quarters · filed 2022-05-25 |
| 2020-06-27 | $105.55M 10-Q · filed 2021-08-11 | $230.48M derived: sum of 2 quarters · filed 2022-05-25 | $361.40M derived: sum of 3 quarters · filed 2022-05-25 | $486.97M derived: sum of 4 quarters · filed 2022-05-25 |
| 2020-03-28 | $124.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-25 | $255.85M derived: sum of 2 quarters · filed 2022-05-25 | $381.42M derived: sum of 3 quarters · filed 2022-05-25 | $503.97M 10-K · filed 2022-05-25 |
| 2019-12-28 | $130.92M 10-Q · filed 2021-02-02 | $256.49M derived: sum of 2 quarters · filed 2021-02-02 | $379.03M 10-Q · filed 2021-02-02 | $517.12M derived: sum of 4 quarters · filed 2021-05-26 |
| 2019-09-28 | $125.57M 10-Q · filed 2020-11-04 | $248.11M 10-Q · filed 2020-11-04 | $386.20M derived: sum of 3 quarters · filed 2021-05-26 | $522.38M derived: sum of 4 quarters · filed 2021-05-26 |
| 2019-06-29 | $122.55M 10-Q · filed 2020-08-04 | $260.63M derived: sum of 2 quarters · filed 2021-05-26 | $396.81M derived: sum of 3 quarters · filed 2021-05-26 | $526.49M derived: sum of 4 quarters · filed 2021-05-26 |
| 2019-03-30 | $138.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-26 | $274.27M derived: sum of 2 quarters · filed 2021-05-26 | $403.94M derived: sum of 3 quarters · filed 2021-05-26 | $550.04M 10-K · filed 2021-05-26 |
| 2018-12-29 | $136.18M 10-Q · filed 2020-02-04 | $265.86M derived: sum of 2 quarters · filed 2020-02-04 | $411.96M 10-Q · filed 2020-02-04 | $541.12M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-09-29 | $129.67M 10-Q · filed 2019-11-01 | $275.78M 10-Q · filed 2019-11-01 | $404.94M derived: sum of 3 quarters · filed 2020-05-20 | $527.69M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | $146.10M 10-Q · filed 2019-08-06 | $275.27M derived: sum of 2 quarters · filed 2020-05-20 | $398.02M derived: sum of 3 quarters · filed 2020-05-20 | $518.83M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | $129.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-20 | $251.91M derived: sum of 2 quarters · filed 2020-05-20 | $372.73M derived: sum of 3 quarters · filed 2020-05-20 | $492.01M 10-K · filed 2020-05-20 |
| 2017-12-30 | $122.75M 10-Q · filed 2019-02-05 | $243.56M derived: sum of 2 quarters · filed 2019-02-05 | $362.85M 10-Q · filed 2019-02-05 | |
| 2017-09-30 | $120.81M 10-Q · filed 2018-11-06 | $240.10M 10-Q · filed 2018-11-06 | ||
| 2017-07-01 | $119.29M 10-Q · filed 2018-08-07 | |||
| 2017-04-01 | $507.62M 10-K · filed 2019-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |